NO992468L - Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID - Google Patents

Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID

Info

Publication number
NO992468L
NO992468L NO992468A NO992468A NO992468L NO 992468 L NO992468 L NO 992468L NO 992468 A NO992468 A NO 992468A NO 992468 A NO992468 A NO 992468A NO 992468 L NO992468 L NO 992468L
Authority
NO
Norway
Prior art keywords
nsaids
treatment
composition
gastrointestinal disorders
containing bismuth
Prior art date
Application number
NO992468A
Other languages
English (en)
Other versions
NO992468D0 (no
Inventor
Jonathan Davidson Kaunitz
Owen Rickford Carryl
Shin Tanaka
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO992468D0 publication Critical patent/NO992468D0/no
Publication of NO992468L publication Critical patent/NO992468L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse vedrører fremgangsmåter og sammen- setninger for å behandle en gastrointestinal forstyrrelse forårsaket eller mediert av Helicobacter pylori, hvilke omfatter vismut, og en gastropatisk mengde av et ikke- steroidalt anti-inflammatorisk medikament. Oppfinnelsen kan ytterligere inneholde terapeutiske effektive mengder av ett eller flere anti-sekretoriske medikamenter.
NO992468A 1996-11-22 1999-05-21 Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID NO992468L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75551796A 1996-11-22 1996-11-22
PCT/US1997/021462 WO1998022118A1 (en) 1996-11-22 1997-11-21 Compositions for the treatment of gastrointestinal disorders containing bismuth and nsaid

Publications (2)

Publication Number Publication Date
NO992468D0 NO992468D0 (no) 1999-05-21
NO992468L true NO992468L (no) 1999-07-01

Family

ID=25039481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992468A NO992468L (no) 1996-11-22 1999-05-21 Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID

Country Status (7)

Country Link
EP (1) EP0941102A1 (no)
CN (1) CN1238694A (no)
CA (1) CA2271381A1 (no)
HU (1) HUP9904073A3 (no)
NO (1) NO992468L (no)
TR (1) TR199901101T2 (no)
WO (1) WO1998022118A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9600070D0 (sv) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
JP2002537336A (ja) * 1999-02-26 2002-11-05 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化されたプロトンポンプ阻害剤、組成物および使用方法
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
TWI289557B (en) 1999-06-17 2007-11-11 Takeda Chemical Industries Ltd A crystal of a hydrate of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
ATE511508T1 (de) * 2000-12-01 2011-06-15 Takeda Pharmaceutical Verfahren zur kristallisation von (r)- oder (s)- lansoprazol
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US6514960B1 (en) * 2001-08-27 2003-02-04 Hedonist Biochemical Technologies Co., Ltd. Use of bismuth subgallate in inhibition of production of nitric oxide synthase
WO2004012659A2 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
EP2596791B1 (en) 2002-10-16 2015-04-01 Takeda Pharmaceutical Company Limited Stable solid preparations
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
KR101148399B1 (ko) * 2005-06-22 2012-05-23 일양약품주식회사 항궤양제 및 점막보호제를 함유하는 경구용 위장질환치료용 약제 조성물
JP2011513202A (ja) 2008-03-10 2011-04-28 武田薬品工業株式会社 ベンズイミダゾール化合物の結晶
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
EP2445499A4 (en) 2009-06-25 2013-02-27 Astrazeneca Ab METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE
UA115139C2 (uk) 2011-12-28 2017-09-25 Поузен Інк. Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
WO2023143573A1 (zh) * 2022-01-30 2023-08-03 上海石趣医药科技有限公司 含铋化合物在用于治疗疾病中的用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI910088A7 (fi) * 1990-01-09 1991-07-10 Brocades Pharma Bv Oraalinen farmaseuttinen koostumus
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
DE69221905T2 (de) * 1991-11-22 1998-01-29 Procter & Gamble Wismutsubsalicylat in form einer einheitsdosis
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten

Also Published As

Publication number Publication date
HUP9904073A2 (hu) 2000-03-28
CN1238694A (zh) 1999-12-15
WO1998022118A1 (en) 1998-05-28
EP0941102A1 (en) 1999-09-15
CA2271381A1 (en) 1998-05-28
NO992468D0 (no) 1999-05-21
TR199901101T2 (xx) 1999-07-21
HUP9904073A3 (en) 2000-04-28

Similar Documents

Publication Publication Date Title
NO992468L (no) Sammensetning for behandling av gastrointestinale forstyrrelser inneholdende vismut og NSAID
NZ235877A (en) Composition comprising acetaminophen or nsaid and an h 1 or h 2 receptor blocker and/or proton pump inhibitor for treating overindulgence
DK1586322T3 (da) Sammensætninger indeholdende thalidomid og dextamethason til behandling af cancer
NO992469L (no) Sammensetninger inneholdende vismut og NSAID samt ett eller fler anti-mikrobielle midler til behandling av gastrointestinale lidelser
DK1024815T3 (da) Farmaceutisk sammensætning til oral administrering af molekylært iod
PT862424E (pt) Composicoes farmaceuticas compreendendo flurbiprofeno
DK0600725T3 (da) Farmaceutiske præparater indeholdende en guanidinothiazolforbindelse og antacider
ATE525061T1 (de) Feste selbst-haftende zusammensetzungen zur topischen behandlung von störungen der mundschleimhaut
ES2165969T3 (es) Compuestos nitrogenados aromaticos condensados 5,5 aril-sustituidos como agentes antiinflamatorios.
PT705100E (pt) Guanidinas substituidas terapeuticas
NO976048D0 (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
DE69009684D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung gastrointestinaler Störungen.
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
PL323617A1 (en) Pharmaceutical preparation for treating oestrogen-dependent carcinomas
TR199800421A2 (xx) Moenomisin grubu antibiyotiklerin bizmut tuzlar�.
MX9305510A (es) Compuestos para el tratamiento o profilaxis de desordenes gastrointestinales, cardiovasculares y del sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
FI941911A0 (fi) Kondensoidut kinolyylidihydropyridiinit, menetelmä niiden valmistamiseksi ja niiden käyttö lääkeaineissa
DK554585D0 (da) Laegemiddel omfattende en forbindelse af mindst et immunotoxin og mindst en mannoseholdig polymer
NO982562L (no) Sammensetning for behandling av smerte
IL127143A0 (en) Phospholipid terivatives of non-steroidal anti inflammatory drugs
IL104464A0 (en) Pharmaceutical compositions containing atypical beta-adrenoceptor agonists for the treatment of gastrointestinal disorders
DK374584D0 (da) Analgetikum
FR2707455B1 (fr) Empêchement de la reproduction des insectes xylophages, moyens pour le traitement préventif du matériau bois mis en Óoeuvre.
SE8504612D0 (sv) Analgetiska och antiinflammatoriska kompositioner innefattande difenhydramin och forfaranden for anvendning av dessa

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application